Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,600
Closed -$829K 403
2023
Q4
$829K Hold
7,600
0.03% 213
2023
Q3
$782K Sell
7,600
-1,100
-13% -$119K 0.06% 198
2023
Q2
$1M Sell
8,700
-500
-5% -$56.8K 0.05% 160
2023
Q1
$979K Sell
9,200
-700
-7% -$75.6K 0.03% 189
2022
Q4
$1.1M Buy
+9,900
New +$1.01M 0.11% 159
2022
Q1
Sell
-57,200
Closed -$33K 442
2021
Q4
$33K Buy
+57,200
New +$4.56M ﹤0.01% 349
2021
Q1
Sell
-16,978
Closed -$60K 532
2020
Q4
$60K Buy
16,978
+4,926
+41% +$377K ﹤0.01% 280
2020
Q3
$66K Buy
12,052
+524
+5% +$41K 0.01% 172
2020
Q2
$115K Sell
11,528
-3,144
-21% -$237K 0.01% 155
2020
Q1
$114K Buy
+14,672
New +$1.15M 0.01% 136

Other funds holding MRK

XR Securities's MRK Position: Q4 2024 in Review

XR Securities sold out of Merck (MRK) in Q4 2024, closing a stake of 1,789 shares — an estimated $203K sold.

XR Securities first reported a position in MRK in Q1 2019 and held it in 11 quarters. The position peaked at $764K in Q1 2019. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • XR Securities reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • XR Securities sold 1,789 Merck shares in Q4 2024, an estimated $203K.
  • XR Securities first reported a position in Merck in Q1 2019 and held it in 11 quarters.
  • XR Securities's Merck position peaked at $764K in Q1 2019.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on XR Securities's 13F filing for Q4 2024, filed 17 Jan 2025.